Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia

View source ↗

Summary

This clinical trial update outlines research into the role of genetic expression of interleukin-1β and interleukin-33 in the pathogenesis of immune thrombocytop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sohag University | Conditions: Immune Thrombocytopenia, System; Lupus Erythematosus | Status: NOT_YET_RECRUITING